Physician profile
Arman Borhan
NPI 1689705535
$2,439.35
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,778 · 2020: $237 · 2021: $124 · 2022: $102 · 2023: $157 · 2024: $41.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $198.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $198.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,553.67 | 2019 | |
| Abbvie INC. | $124.08 | 2022-2023 | Ubrelvy |
| Medtronic USA, INC. | $118.18 | 2019-2020 | |
| Medtronic, INC. | $79.82 | 2021-2024 | Intellis Adaptivestim |
| Boston Scientific Corporation | $60.81 | 2019-2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $55.05 | 2019-2021 | |
| Pfizer INC. | $43.62 | 2019-2020 | |
| Lilly USA, LLC | $37.58 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $34.61 | 2019 | |
| Biodelivery Sciences International, INC. | $30.32 | 2021 | |
| Nevro Corp. | $26.28 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $23.80 | 2022 | |
| Pacira Therapeutics, INC. | $23.57 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $22.91 | 2019-2020 | |
| Amgen INC. | $21.82 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $20.51 | 2019 | |
| Arbor Pharmaceuticals, INC. | $19.61 | 2021 | |
| Scilex Pharmaceuticals INC. | $18.56 | 2023 | Ztlido |
| Stryker Corporation | $18.06 | 2023 | Spinejack |
| Abbott Laboratories | $17.50 | 2019 | |
| Novo Nordisk INC | $16.87 | 2023 | Wegovy |
| Radius Health, INC. | $16.38 | 2020 | |
| Redhill Biopharma INC. | $15.45 | 2020 | |
| Horizon Therapeutics Plc | $13.95 | 2019 | |
| Vertos Medical, INC. | $13.41 | 2020 | |
| Bard Peripheral Vascular, INC. | $12.93 | 2023 | Venclose Maven Catheter |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arman Borhan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.